Medicinova Inc (MNOV)

Sep 30, 2025

Can a trend reversal in MediciNova Inc. lead to recoveryMarket Sentiment Summary & Breakout Confirmation Trade Signals - newser.com

Sep 30, 2025

Sep 30, 2025

What drives MediciNova Inc stock priceAnalyst Downgrades & Small Budget Trading Ideas - earlytimes.in

Sep 30, 2025

Sep 30, 2025

MediciNova Inc. recovery potential after sell offQuarterly Performance Summary & Reliable Volume Spike Trade Alerts - newser.com

Sep 30, 2025

Sep 30, 2025

Long term hold vs stop loss in MediciNova Inc.2025 Technical Overview & Free Risk Controlled Daily Trade Plans - newser.com

Sep 30, 2025

Sep 30, 2025

Why MediciNova Inc. stock is favored by top institutions2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com

Sep 30, 2025

Sep 30, 2025

Will MediciNova Inc. stock benefit from sector rotationEarnings Recap Report & Daily Profit Focused Screening - newser.com

Sep 30, 2025

Sep 30, 2025

What MACD signals say about MediciNova Inc.2025 Major Catalysts & Daily Stock Trend Reports - newser.com

Sep 30, 2025

Sep 29, 2025

What does recent volatility data suggest for MediciNova Inc.July 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com

Sep 29, 2025

Sep 29, 2025

Custom strategy builders for tracking MediciNova Inc.Portfolio Value Report & AI Enhanced Trading Alerts - newser.com

Sep 29, 2025

Sep 27, 2025

Is MediciNova Inc a good long term investmentSupport and Resistance Levels & Interactive Learning for Better Returns - Early Times

Sep 27, 2025

Sep 24, 2025

StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - 富途牛牛

Sep 24, 2025

Sep 23, 2025

MediciNova (NASDAQ:MNOV) Receives “Buy” Rating from D. Boral Capital - Defense World

Sep 23, 2025

Sep 22, 2025

MediciNova completes patient enrollment in phase 2/3 ALS trial - Investing.com India

Sep 22, 2025

Sep 22, 2025

MediciNova completes patient enrollment in phase 2/3 ALS trial By Investing.com - Investing.com South Africa

Sep 22, 2025

Sep 22, 2025

MediciNova (MNOV) Maintains "Buy" Rating from D. Boral Capital | - GuruFocus

Sep 22, 2025

Sep 22, 2025

MediciNova (MNOV) Completes Enrollment for Key ALS Treatment Tri - GuruFocus

Sep 22, 2025

Sep 22, 2025

MediciNova Completes Patient Enrollment in Phase 2b/3 Trial of Ibudilast for Treatment of ALS - MarketScreener

Sep 22, 2025

Sep 22, 2025

MediciNova Announces Completion of Patient Enrollment - GlobeNewswire

Sep 22, 2025

Sep 22, 2025

MediciNova Announces Completion of Patient Enrollment in COMBAT- - GuruFocus

Sep 22, 2025

Sep 22, 2025

234 ALS Patients Enrolled: MediciNova's Fast-Track Drug Trial Could Offer New Hope for Fatal Disease - Stock Titan

Sep 22, 2025

Sep 22, 2025

MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast) - Yahoo Finance

Sep 22, 2025

Sep 21, 2025

Building trade automation scripts for MediciNova Inc.Weekly Volume Report & Community Shared Stock Ideas - newser.com

Sep 21, 2025

Sep 20, 2025

Gains Report: What is the next catalyst for MediciNova IncProfit Target & High Return Trade Opportunity Guides - خودرو بانک

Sep 20, 2025